Cephalon, Inc. v. Watson Pharmaceuticals, Inc.

Procedural entryThis page is a short order in Cephalon, Inc. v. Watson Pharmaceuticals, Inc.. Read the opinion of the Court — 707 F.3d 1330
Court of Appeals for the Federal Circuit·Decided October 13, 2011·No. 2011-1325·Unpublished

Opinion

NOTE: This order is nonprecedential United States Court of AppeaIs for the Federal Circuit CEPHALON, INC. AND CIMA LABS, INC., Plaintiffs-Appellants, - V. WATSON PHARMACEUTICALS, INC., WATSON LABORATORIES, INC., AND WATSON PHARMA, INC., Defendants-Appellees. _ 2011-1325 Appea1 from the United States District Court for the District of De1aWare in case no. 08-CV-0330, Judge Sue L. R0binS0n. ON MOTION ORDER Cepha1on, Inc. and CIMA Labs, Inc., move for a 30- day extension of time, until November 16, 2011, to file their opening brief due to settlement negotiationS. Upon consideration thereof IT ls ORDEREio THAT:

CEPI~lALON V. WATSON PHARMA 2 The motion is granted No further extensions should be anticipated FOR THE COURT 0CT 1 3 2U|1 /s/ Jan H0rba1§{ Date Jan Horba1y C1erk cc: Wi11ia1n F. Lee, Esq. F| go J ames K. Stronski, Esq. s'S"IM§fig|?Af_Ff§EAohslf:0R 321 oct 13 2011 JAN|'DRBN.¥ CLERK

Free access — add to your briefcase to read the full text and ask questions with AI

Cephalon, Inc. v. Watson Pharmaceuticals, Inc., (Fed. Cir. 2011).

Cephalon, Inc. v. Watson Pharmaceuticals, Inc. (Cephalon, Inc. v. Watson Pharmaceuticals, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.